Login

V-Cube Revolutionizes Virtual Collaboration Through Integration with Zoom Platform | Kazunori Yahata At V-cube Inc 00:10:00

Share On Facebook Share On Twitter

V-cube Inc. - New Business Development

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Chen Rui on Bilibili’s Global Success: From Shanghai Startup to $30 Billion Valuation | Chen Rui, CEO, Bilibili Inc.
00:10:00
AI in Investing: Unlocking Alpha Through Future-Focused Sectors | Mark Bova, Co-Founders , Lenity Financial, Inc.
00:00:00
Pioneer in personal genomics and synthetic biology / George Church, Ph.D. Robert Winthrop Professor of Genetics, Harvard Medical School
00:10:00
Renewable Energy CEO Xavier Barbaro Discusses Europe's Ambition, Challenges, and the Path Forward | Xavier Barbaro, CEO, Neoen SA.
00:10:00
Edtech pre-seed investment fund seeking founders with long-term mindsets|Justin Su,Founder,Long Term Impact
00:10:00
Two years post-IPO, TELUS International has expanded its workforce by 25,000 and increased revenues from $1.6 billion to $2.5 billion.
00:10:00
Embracing personal experiences and a vision for sustainability | Pieter Loose, CEO, Ekopak NV.
00:10:00
Forecasting the Future: A Decade of Change with Hamish Douglass and Andrew Clifford | Andrew Clifford , CEO , Platinum Asset Management.
00:10:00
April Update from Nathan Mersereau, President of Planning Alternatives | Nathan Mersereau, President, Planning Alternatives Ltd.
00:10:00
Understanding 401(k) Rollovers: When to Move Your Retirement Funds
00:00:00
Satyajit T. Reddy, M.D. Cardiologist, Mayo Clinic
00:10:00
Shahar Bar, SVP of Video Products & Corporate Development at Harmonic Inc., discusses competition in the media industry.

© 2017 - Neuhu+